[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.134.98. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Research Letter
Jan/Feb 2019

Opioid Prescription Patterns After Rhinoplasty

Author Affiliations
  • 1Department of Otolaryngology, Harvard Medical School, Boston, Massachusetts
  • 2Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology, Massachusetts Eye and Ear, Boston, Massachusetts
JAMA Facial Plast Surg. 2019;21(1):76-77. doi:10.1001/jamafacial.2018.0999

The opioid epidemic is drawing national attention because opioid-related deaths have increased 200% since 2000.1 The epicenter of the epidemic is the United States, where 4.7% of the world’s population consumes two-thirds of the world’s opiate supply.2 Most persons who abuse opioid drugs are not the intended recipient of the opioids, and more than half of abusers receive pills through friends and family. Therefore, surgeon prescribers play an important role.3 Rhinoplasty is one of the most common procedures performed by facial plastic surgeons, and managing postoperative rhinoplasty pain without contributing to the opioid epidemic is imperative. There are currently few studies examining postrhinoplasty opioid needs based on patient survey data4 but ours is the first, to our knowledge, to use a statewide electronic opioid registry.

×